Mostrando 241,101 - 241,120 Resultados de 241,709 Para Buscar '"The Nation"', tiempo de consulta: 1.24s Limitar resultados
  1. 241101
    “…The clinical specifications for the California P4P program are based on the national Committee for Quality assurance (nCQa), Health Plan Employer Data, and information set (HEDis), and each clinical measure has its own benchmark. in 2005, participating medical groups were paid on the basis of 9 clinical measures that were evaluated in the 2004 measurement year. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 241102
    “…Study drugs were either FDA-approved for breast cancer or recommended for use as preferred single agents per National Comprehensive Cancer Network (NCCN) clinical practice guidelines for breast cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 241103
    “…Additionally, with elevated TG levels, a combination of LDL-C with VLDL-Cin the measure of non-HDL-C may be a better predictor of cardiovascular risk than LDL-C alone. Recent national treatment guidelines suggest that combination therapymay be necessary to address multiple lipid targets (i.e., LDL-C, non-HDL-C,HDL-C, and TG); adding niacin or a fibrate to a statin is a therapeutic option that should be considered. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 241104
  5. 241105
    “…METHODS: The study is a secondary analysis of the 2004 Medicare Current Beneficiary Survey (MCBS), an ongoing national panel survey conducted by the Centers for Medicare and Medicaid Services (CMS). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 241106
    “…BACKGROUND: In January 2009, the Joint Commission implemented a National Patient Safety Goal (NPSG) for ambulatory care, NPSG 3E, intended to reduce harm associated with the use of anticoagulation therapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 241107
    “…Data for EOSADD and US PSEN1 subjects (with multiple different mutation types) was obtained from the National Alzheimer Coordinating Center (NACC). Colombian cases all had the E280A mutation and had a set of neuropathological observations classified, like the US cases according to the NACC NP10 definitions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 241108
    “…STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants from the Ministry of Science and Technology of China (2018YFC1005001) and National Natural Science Foundation of China (31601197). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 241109
    “…Background: Epidemiologic studies of unselected (medically unbiased) populations in many nations indicates that PCOS is clinically evident in 5%-15% of all reproductive-aged women. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 241110
  11. 241111
  12. 241112
    “…Grant Recipient; Self; GLIA-CTN from National Institute of Neurological Disorders and Stroke (NINDS). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 241113
    “…The original METS study was funded by 10.13039/501100000024Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, 10.13039/501100000226Ontario Ministry of Health and Long-Term Care, 10.13039/501100003400Ontario Ministry of Research, Innovation and Science, UK National Institute of Academic Anaesthesia, 10.13039/100011417UK Clinical Research Collaboration, 10.13039/501100001136Australian and New Zealand College of Anaesthetists, and 10.13039/501100001779Monash University.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 241114
    “…Electronic health record data relating to people in a national England database (NHS England’s Secure Data Environment, accessed via the BHF Data Science Centre's CVD-COVID-UK/COVID-IMPACT consortium) were analysed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 241115
    “…Whereas the quality of cohort studies was assessed using the National Institutes of Health (NIH) tool. Results: The systematic search of databases retrieved a total of 2576 studies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 241116
    “….: Grant/Research Support|National Institutes of Health: Grant/Research Support|Pfizer Inc.: Grant/Research Support|Roche Holding AG: Grant/Research Support|Shionogi Inc.: Grant/Research Support|Summmit Therapeutics, Inc.: Grant/Research Support|Zoetis Inc: Grant/Research Support Rodrigo E. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 241117
    “…CURE ID, a web-based repository developed by the FDA and the National Center for Advancing Translational Sciences (NCATS) to gather real-world data (RWD) on the novel uses of existing drugs for difficult-to-treat infectious diseases. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 241118
    “…We obtained post-TB treatment mortality data from the Centers for Disease Control and Prevention National Death Index and general Georgia population death rates and causes of death for the same period from public databases. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 241119
    “….: Grant/Research Support|National Institutes of Health: Grant/Research Support|Pfizer Inc.: Grant/Research Support|Roche Holding AG: Grant/Research Support|Shionogi Inc.: Grant/Research Support|Summmit Therapeutics, Inc.: Grant/Research Support|Zoetis Inc: Grant/Research Support Rodrigo E. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 241120
    “…Richard Hobbs, FMedSci, AstraZeneca: Grant/Research Support|National Institute for Health and Care Research: Grant/Research Support|UK Research and Innovation: Grant/Research Support Hugh Montgomery, MD, AstraZeneca: Advisor/Consultant|Millfield Medical Electronics Ltd: Advisor/Consultant Francisco Padilla, MD, Amgen: Grant/Research Support|AstraZeneca: Grant/Research Support|Boehringer Ingelheim: Grant/Research Support|Ferrer: Grant/Research Support|Kowa: Grant/Research Support|Medix: Grant/Research Support|Merck: Grant/Research Support|Merck Sharp and Dohme: Grant/Research Support|Novartis: Grant/Research Support|Pfizer: Grant/Research Support|Sanofi: Grant/Research Support|Servier: Grant/Research Support|Silanes: Grant/Research Support Jesus Abraham Simón Campos, MD, AstraZeneca: Expert Testimony|Atea: Advisor/Consultant|Eli Lilly: Advisor/Consultant|Pfizer: Expert Testimony|Regeneron: Expert Testimony|Roche: Expert Testimony Douglas Arbetter, MPH, AstraZeneca: Employement|AstraZeneca: Stocks/Bonds Seth Seegobin, PhD, AstraZeneca: Employee|AstraZeneca: Stocks/Bonds Alexandre Kiazand, MD, AstraZeneca: Employee|AstraZeneca: Stocks/Bonds Katie Streicher, PhD, AstraZeneca: Employee|AstraZeneca: Stocks/Bonds Nuria Martinez-Alier, PhD, AstraZeneca: Employee|AstraZeneca: Employement|AstraZeneca: Stocks/Bonds|AstraZeneca: Stocks/Bonds Taylor Cohen, PhD, AstraZeneca: Employement|AstraZeneca: Stocks/Bonds Mark T. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS